0.2739
price up icon0.92%   +0.0025
 
loading
FOXO Technologies Inc stock is currently priced at $0.2739, with a 24-hour trading volume of 53,644. It has seen a +0.92% increased in the last 24 hours and a -13.35% declined in the past month. The chart indicates a potential bullish trend, as the stock is above the $0.2716 pivot point. If it approaches the $0.2778 resistance level, significant changes may occur.
Previous Close:
$0.2714
Open:
$0.2679
24h Volume:
53,644
Market Cap:
$2.45M
Revenue:
$453.00K
Net Income/Loss:
$-40.92M
P/E Ratio:
-
EPS:
-
Net Cash Flow:
$-10.69M
1W Performance:
-1.37%
1M Performance:
-13.35%
6M Performance:
-26.95%
1Y Performance:
+0.00%
1D Range:
Value
$0.2654
$0.2747
52W Range:
Value
$0.0552
$0.85

FOXO Technologies Inc Stock (FOXO) Company Profile

Name
Name
FOXO Technologies Inc
Name
Phone
(612) 562-9447
Name
Address
729 North Washington Avenue, Suite 600, Minneapolis
Name
Employee
15
Name
Twitter
Name
Next Earnings Date
2024-05-24
Name
Latest SEC Filings
Name
FOXO's Discussions on Twitter

FOXO Technologies Inc Stock (FOXO) Financials Data

FOXO Technologies Inc (FOXO) Revenue 2024

FOXO reported a revenue (TTM) of $453.00 thousand for the quarter ending September 30, 2023, a +277.50% rise year-over-year.
loading

FOXO Technologies Inc (FOXO) Net Income 2024

FOXO net income (TTM) was -$40.91 million for the quarter ending September 30, 2023, a +47.41% increase year-over-year.
loading

FOXO Technologies Inc (FOXO) Cash Flow 2024

FOXO recorded a free cash flow (TTM) of -$10.69 million for the quarter ending September 30, 2023, a +56.23% increase year-over-year.
loading

FOXO Technologies Inc (FOXO) Earnings per Share 2024

FOXO earnings per share (TTM) was -$15.61 for the quarter ending September 30, 2023, a +79.97% growth year-over-year.
loading
FOXO Technologies Inc. engages in epigenetic biomarker underwriting technology and consumer engagement platform service business in the United States. It operates through two segments, FOXO Labs and FOXO Life. The company applies automated machine learning and artificial intelligence technologies to discover epigenetic biomarkers of human health, wellness, and aging. It offers FOXO Labs, a commercializing proprietary epigenetic biomarker technology enables the adoption of saliva-based health and wellness biomarker solutions for underwriting and risk assessment; and FOXO Life, a sales and distribution platform focused on recruiting independent life insurance agents to sell life insurance with the Longevity Report. The company was founded in 2020 and is based in Minneapolis, Minnesota. FOXO Technologies Inc. is a subsidiary of FOXO Management LLC.
$7.61
price up icon 1.06%
health_information_services TXG
$25.36
price down icon 2.98%
$32.16
price down icon 2.72%
health_information_services EVH
$27.27
price down icon 1.23%
$23.88
price down icon 2.01%
health_information_services RCM
$12.84
price up icon 3.13%
Cap:     |  Volume (24h):